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Reif and  Allen  (1-3)  demonstrated  that  0-antigen was present  on the  surface of 
mouse thymocytes and a  number of murine leukemia cells,  in brain tissue and, to a 
lesser extent, in lymph nodes and spleen.  They later showed that 0-antigen was con- 
trolled  by a  single  locus with two alleles:  8-AKR found in AKR mice,  and  0-C3H 
found in most inbred strains of mice, including CBA. 
Golub  (4) has employed the fact that 0-antigen is present in brain to produce an 
antibrain-associated  0-antiserum  (BA0) 1 by injecting mouse brain into rabbits.  The 
activity of BA0 antiserum parallels that of AKR anti-0 C3H and C3H anti-0 AKR. 
The  relationship  between  O-C3H,  8-AKR,  and  BA0  has  recently  been  shown  by 
Clagett et al.  (5)  and Peter et al.  (6)  to consist of a  complex system of shared and 
unshared  antigens between mouse 8-C3H, 0-AKR, and rat Lewis  (Le)  thymocytes. 
The immunochemical reactions  of lipids have been  the subject of a  review 
(7). Among the most studied of these antigens of haptenic determinants are the 
Forssman  hapten  (8,  9),  cytolipin  R,  K,  and  H  (7),  and  the  ABH  and Le  b 
isoantigens  (10). Antisera can be prepared  toward gangliosides  with  extended 
immunization schedules using pure gangliosides or brain (11,  12). 
We now describe  the partial  characterization  of a  lipid which has been iso- 
lated from mouse thymocytes and brain, and which is capable of inhibiting the 
cytotoxicity of anti-BAO antiserum. The data presented here are consistent with 
the proposal that BAO antigen is GDlb ganglioside. 
Materials and Methods 
Animals.---CBA/J female mice 4-12-wk old were used as donors of thymocytes and brains" 
Young Dutch Belt rabbits  (3 kg) were used for preparation  of antisera. 
Thymocytes.--Care was exercised upon removal of mouse thymus to avoid contamination 
with surrounding mediastinal lymph nodes. Thymuses were placed in Eagle's minimal essen- 
* Supported in part by grants from the National  Cancer Institute  (CA-13396) and from 
the Kidney Foundation of Michigan  (ORD 12164). 
1  Abbrevlatlons used in this paper: BAO, brain-associated  0-antigen;  Gal, galactosyl;  Glc, 
glucosyl;  GalNAc, N-acetylgalactosaminyl;  NANA, N-acetylneuraminyl;  cer, ceramide  (2- 
N-acylsphingosine);  GM3, NANA-Gal-Glc-cer;  GM2, GalNAc-Gal(NANA)-Glc-cer;  GMI, 
Gal-GalNAc-Gal(NANA)-Glc-cer;  GDla, Gal(NANA)-GalNAc-Gal(NANA)-Glc-cer;  GDXb, 
Gai-GalNAc-Gal(NANA-NANA)-Glc-cer;  Crrl, Gal(NANA)-GalNAc-Gal(NANA-NANA)- 
Glc-cer; GD2, GalNAc-Gal(NANA-NANA)-Glc-cer. Gangliosides are abbreviated  according 
to the nomenclature  of Svennerholm (19). 
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tial medium (MEM) and dispersed by mincing the organs with iris scissors. This step was fol- 
lowed by successive aspiration with syringe and needles progressively from a  19 gauge needle 
to a  23 gauge and finally a  27 gauge. Cells were suspended in culture medium after a single 
wash. 
Anti-CBA/Y Brain Antiserum.--Bralns  of CBA/J were removed, homogenized,  and  in- 
jected into Dutch Belt rabbits for production of anti-BA0 according to protocol used by Golub 
(13).  The cytotoxic titer of the antiserum used for all the experiments reported herein was 
1 : 128. 
Absorption of Antisera and Complement.--The antisera and normal rabbit serum (C) were 
absorbed with CBA/J mouse erythrocytes, liver, and agarose (14). 
Cytotoxic Tests.--O.05 ml of absorbed rabbit anti-CBA brain diluted 1:10 was added to 0.l 
ml of cells at a density of 2 X  107/ml. 0.05 ml of absorbed C was added next and the mixture 
was  incubated  1 h  at  37°C. Cytotoxic potency of the  antisera was determined  by trypan 
blue exclusion.  The cytotoxic index (C.I.) was calculated from the following formula: 
%  dead with antiserum -- %  dead with normal rabbit serum 
C.I.= 
100 -- %  dead with normal rabbit serum 
A killing of 100% of the cells would give a  C.I. of 1.0. Absorptions of antibrain serum with 
lipid fractions (prepared as discussed  below)  were incubated for 1 h  before incubation with 
thymocytes and complement. 
Lipid Extra~tion.--CBA/J  brain or thymocyte gangliosides were prepared by homogeniza- 
tion of 8.3 g of CBA/J brains or 2.4 X  109 CBA/J thymocytes with chloroform-methannl 2:1 
(vol/vol) in a  Waring blender (Waxing Products  Div., Dynamics  Corp.  of America, New 
Hartford, Conn.) as described previously (15). The extract was submitted to a Folch partition 
(16), the ganglioside-rich upper layer was dialyzed and the nondialyzable material was evapo- 
rated  to dryness in vacuo and further purified by  thin-layer chromatography.  All solvents 
were redistilled before use. Further details of isolation and separation procedures are given in 
another report (15). 
Thin-Layer Chromatography,--Dialyzed upper phases were evaporated to dryness in vacuo 
and applied to a thin-layer plate of 0.25 mm of Silica Gel G (Analtech, Inc., Wilmington, Del.). 
The plates were developed with chloroform-methanol-2.5 N  ammonium hydroxide 60:40:9 
(vol/vol/vol) in unlined  thin-layer tanks.  Ganglioside-containing areas were visualized by 
spraying with resorcinol solution (17). Areas to be used for immunological or chemical tests 
were visualized with iodine vapors, and bands were scraped into disposable pipettes with glass 
wool plugs which were eluted with  10-15  ml of chloroform-methanol-water  10:10:3  (vol/ 
vol/vol). Blueprints were made of resorcinol- or iodine-stained plates using diazo paper (18). 
Sialic acid was determined by the modified method (19) of Svennerholm. 
Auxiliary  Lipids.--Mixed  upper-phase  (ganglioside-rich)  lipids and  purified lipids were 
formulated with cholesterol-lecithin (auxiliary lipid) mixtures. The glycolipid (1-4/~g)  and 
the auxiliary lipids (5 #g cholesterol and 5 #g lecithin [Supelco,  Inc., Bellefonte, Pa.])  were 
mixed in a  small volume of chloroform-methanol 1:1. The solvents were evaporated under 
nitrogen and 50 #1 of water was added, followed by sonication in an ultrasonic cleaner (Mettler 
Electronics Corp., Anaheim, Calif.) for 30 s, and heating at 100°C for 1 rain. The emulsion 
was made isotonic with 50/zl of 1.7% NaCI and mixed on a vortex mixer. 
RESULTS 
Total  lipid  extracts  prepared  from  CBA/J  mouse  thya~qocytes  were  parti- 
tioned  between  chloroform-methanol-water  two-phase  systems.  The  lower 
phase  (neutral  lipids)  and  the  upper  phase  (ganglioside-rich)  were  tested  for 
inhibitory  activity  (Table  I).  Lower-phase  lipids  demonstrated  little  or  no F.SSELMAN  AND  MILLER  BRIEF  DEFINITIVE  REPORT 
TABLE I 
Inhibition  of Cytotoxicity with Thymocyte Lipid Extracts 
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Lipid  Cells  Cholesterol:  Cytotoxicity 




2.4 X  105  0:0:~  0.86§ 
2.4 ×  108  0:0  0.84 
2.4 )< l0  T  0:0  0.74 
4.8 X 105  0.05:0.05  0.81 
4.8 X 106  0.5:0.5  0.35 
4.8 ×  l0  T  5:5  0.01 
* Upper and lower phase refer to the Folch partition (see Materials and Methods). 
:~ Cholesterol and lecithin were not used with lower phase !ipid mixtures. 
§ Unabsorbed controls gave a  C.I. of 0.84-0.89. 
ability to inhibit the cytotoxicity of anti-BA0 antiserum. This fraction was not 
mixed with auxiliary lipids because cholesterol and lecithin are present in the 
lower-phase  lipid  mixture.  Upper-phase  thymocyte  lipids  extracted  from 
4.8  X  107  cells  completely inhibited cytotoxity (C.I.  =  0.0/).  The antigen 
preparation from 4.8 X  105 cells gave no inhibition (C.I.  =  0.81).  The upper 
phases derived from lipid extracts of CBA/J brain  (0-positive)  and 'CBA/J 
kidney (0-negative)  (2)  were also  tested for activity. The upper phase from 
0.45  mg of brain  (cholesterol:lecithin; 0.5  /zg:0.5  /~g) significantly inhibited 
cytotoxicity (C.I.  ---  0.35).  On the other hand, little or no inhibition of cyto- 
toxicity was observed with the extract of 10 mg of kidney (cholesterol:lecithin, 
5/zg:5/~g) (C.I. =  0.71). 
Upper-phase  lipids were separated by thin-layer chromatography (Fig.  1) 
and  isolated as described  in  the Materials and  Methods.  Individual mouse 
brain (MB) gangliosides were identified by comparison of their RI and pattern 
to human brain gangliosides (HB) of known structure (20). Thymocyte upper- 
phase lipids or gangliosides were compared to mouse and human brain ganglio- 
sides  by thin-layer Rf.  Strong  resorcinol  reactions  were  obtained with  the 
brain gangliosides, but the thymocyte lipids gave only weak reactions because 
of the small amount of material present. 
The  isolated  lipids  were  formulated with  auxiliary lipids  and  tested  for 
ability to inhibit cytotoxicity  of anti-BA  0 antiserum (Table II). Area E  (Fig. 1) 
of the thymocyte lipids (TC) was capable of complete inhibition (C.I. =  0.01). 
The only other thymocyte lipid demonstrating slight activity was the adjacent 
area F  (C.I.  =  0.70),  and this probably represents overlap with area E. Com- 
parable  inhibition  was  obtained  from  upper-phase  lipids  extracted  from 
4.8 X  l0 T  thymocytes, C.I. =  0.01 (Table I) and isolated lipid from 5.9 X  107 
thymocytes, C.I.  =  0.01  (E, Table II). These results indicate a high yield of 
active BA0 antigen during the purification steps. 
The most active fraction among the brain gangliosides had a  thin-layer RI 448  ESSELMAN  AND  MILLER  BRIEF  DEFINITIVE  REPORT 
Fro.  1. Thin-layer chromatography  of mouse brain  and thymocyte  upper-phase  lipids. 
Human brain (HB), mouse brain (MB), and thymocyte  (TC) upper-phase lipids were chro- 
matographed and visualized with iodine vapors. Letters on the right refer to TC lipids and the 
ganglioside nomenclature on the left refers to HB and MB gangliosides. Spots appearing near 
GMa and GM2 are unknown lipids and Cn~3  and C~2 were not visualized because of their low 
concentration. 
TABLE II 
Inhibition of Cytotoxidty with Isolated Thymocyte and Brain Lipids 
Thymocyte  Cytotoxlcity  Brain  Cytotox[city 
lipld*  index  ganglioside  /Zg§  index 
A~t  0.93  G~8, GM2  0.40  0.84 
B  0.94  GM1  22.20  0.82 
C  0.88  GDI~  6.05  0.83 
D  0.80  GD~  1.80  0.71 
E  0.01  GDXb  2.19  0.07 
F  0.70  GTI  2.10  0.46 
* Each thymocyte lipid and brain ganglioside was formulated with 5/~g of cholesterol and 
5/zg of lecithin. 
Letters refer to thyrnocyte lipids in Fig. 1 (extracted 5.9 X 10 7 cells). 
§ Micrograms of ganglioside added is based on the number of micrograms of sialic acid in 
the isolated lipid. The amounts reflect the relative proportions of the gangliosides isolated. 
identical to  Grab ganglioside and with the active thymocyte lipid. Inhibitory 
activity associated with GT1 and to a much lesser extent with Gm was probably 
due to overlap with the active Grab fraction. When the gangliosides were further 
purified by thin-layer chromatography only the C~xb fraction was inhibitory. 
Furthermore, the amount of Grab used in this assay was much more than the 
amount necessary to give complete inhibition, as little as 0.39 #g of G~lb gave 
a  C.I. of 0.04. 
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finding that  auxiliary lipids were essential for activity. No  activity was  ob- 
served  when  1.19 #g  of  Grab  ganglioside  was  formulated  without  auxiliary 
lipids (C.I.  =  0.84). When as little as 1 #g each of cholesterol and lecithin was 
added to the preparation complete inhibition was observed (C.I.  =  0.07). 
The possibility that the glycolipid antigen was interacting with complement 
was  eliminated by absorbing the antiserum with the antigen,  followed by a 
period  of  incubation  with  thymocytes. The  thymocytes were  then  washed 
to remove glycolipid antigen and complement was added. The same degree of 
lysis was observed in this case as in experiments where lysis was performed as 
described in the Materials and Methods. 
DISCUSSION 
This report describes the partial characterization of an antigen which has 
been isolated from mouse thymocytes and brain and which is capable of in- 
hibiting  the  cytotoxicity of anti-BA0  antiserum.  The antigen is  extractable 
into lipid solvents and is located in the upper-aqueous phase of a Folch partition 
(16). The antigen is water "soluble," requires auxiliary lipids for immunological 
activity, and migrates, by thin-layer chromatography with GDlb ganglioside. 
These data are consistent with the proposal that BA0 antigen is GDlb ganglioside. 
Reif and  Allen  (3)  reported  that  0-C3HeB/Fe isoanfigen  of thymus was  non- 
dialyzable  and could not be recovered in active form after treatment with lipid sol- 
vents, such as chloroform-methanol 2 : 1 (vol/vol). The active ganglioside reported here 
is nondialyzable  in spite of its low tool wt (about 2,000) because it exists in solution 
in large aggregates or micelles (7). 
Antisera to bovine brain have been found to have antibodies specific for gangliosides 
(12) and antisera to bovine brain gangliosides were found to contain antibodies for 
Gi)lb and GM1 (11, 12). From this information we conclude that there are anti-GDlb 
antibodies in the rabbit antimouse brain antisera and that this ganglioside, exposed 
on the surface of thymocytes and T lymphocytes, is responsible for the cytotoxicity 
of the anti-BA0 antisera. 
Atwell et al. (21) have reported that 0-antigen is a protein with a mol wt of 
about 60,000 daltons. Using a similar system of immunoprecipitation of radio- 
iodinated cell-surface proteins, we were unable to precipitate significant protein 
material  (assessed  by  SDS-gel electrophoresis) using  rabbit  anti-CBA  brain 
antiserum. The antigenic activity specified by AKlZ anti-e C3H antiserum, on 
the other hand, may be different from the antigen activity specified by rabbit 
anti-CBA brain antiserum. The difference, if any, remains to be determined by 
examining the specificity of AKR anti-0 C3H antiserum. 
Addendum: Vitetta et al. (22) have recently presented evidence that the 0-antigen 
(or Thy 1) of murine thymocytes is a glycolipid. 
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